Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

KRX/005500 stock hub

KRX/005500 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/005500is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

223B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/005500

In the news

Latest news · KRX/005500

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E10.9

P25 9.8P50 17.1P75 31.9

Trailing P/E10.5

P25 12P50 23.1P75 39.5

ROE8.6

P25 -17.1P50 0.7P75 8.5

ROIC6.3

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/005500 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

227

Groups with data

Currency

KRW

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Employees	586
Employees Change	-12%
Employees Change Percent	-2.1
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KR7005500004
Last refreshed	2026-05-10
Market cap	KRW 223B
Price	KRW 18,190
Price currency	KRW
Rev Per Employee	467,631,072.42x
Sector	Healthcare
Sic	2834
Symbol	krx/005500
Website	https://www.samjinpharm.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	9.82%
FCF yield	-8.1%
Forward P/E	10.93x
P/B ratio	0.81x
P/E ratio	10.53x
P/S ratio	0.81x
PE Ratio10 Y	26.88x
PE Ratio3 Y	18.98x
PE Ratio5 Y	20.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.46%
EBITDA Margin	12.04%
Gross margin	42.96%
Gross Profit	KRW 117.7B
Gross Profit Growth	6.74%
Gross Profit Growth Q	3.34%
Gross Profit Growth3 Y	-1.45%
Gross Profit Growth5 Y	5.03%
Net Income	KRW 21.9B
Net Income Growth	48.96%
Net Income Growth Q	59.06%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	25.38%
Net Income Growth5 Y	26.45%
Pretax Margin	9.21%
Profit Margin	7.99%
Profit Per Employee	KRW 37.4M
Profitable Years	19
ROA	3.92
ROCE	7.14
ROE	8.59
ROIC	6.33
Roic5y	8.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.22%
Cagr15y	7.54%
Cagr1y	6.41%
Cagr20y	5.21%
Cagr3y	-3.54%
Cagr5y	-3.9%
Div CAGR10	1.34%
Div CAGR3	0%
Div CAGR5	0%
EPS Growth	52
EPS Growth Q	64.31
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	27.01
EPS Growth5 Y	27.52
FCF Growth Q	26.32%
OCF Growth	-39.16%
OCF Growth Q	-78.6%
OCF Growth3 Y	-10.97%
OCF Growth5 Y	79.07%
Revenue Growth	45.04x
Revenue Growth Q	-1.45x
Revenue Growth Years	5x
Revenue Growth3 Y	9.78x
Revenue Growth5 Y	12.94x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.74
Assets	KRW 406.6B
Cash	KRW 4.7B
Current Assets	KRW 136.9B
Current Liabilities	KRW 78.9B
Debt	KRW 87.5B
Debt EBITDA	KRW 2.65
Debt Equity	KRW 0.32
Debt FCF	KRW -4.85
Equity	KRW 275.9B
Interest Coverage	13.15
Liabilities	KRW 130.7B
Long Term Assets	KRW 269.6B
Long Term Liabilities	KRW 51.7B
Net Cash	KRW -82.8B
Net Cash By Market Cap	KRW -37.16
Net Debt EBITDA	KRW 2.51
Net Debt Equity	KRW 0.3
Tangible Book Value	KRW 265B
Tangible Book Value Per Share	KRW 20,029
WACC	4.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.64
Inventory Turnover	2.26
Net Working Capital	KRW 92.8B
Quick ratio	0.79
Working Capital	KRW 52.6B
Working Capital Turnover	KRW 4.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	KRW 800
Dividend Years	33
Dividend Yield	4.4%
Ex Div Date	2025-12-29
Last Dividend	KRW 800
Payout Frequency	Annual
Payout Ratio	44.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-11.53%
1Y total return	6.41%
200-day SMA	19,412.4
3Y total return	-10.24%
50-day SMA	18,440.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-18.02%
All Time High	64,900
All Time High Change	-71.97%
All Time High Date	2018-09-28
All Time Low	1,823.9
All Time Low Change	897.29%
All Time Low Date	1994-01-27
ATR	349.7
Beta	0.17
Beta1y	0.12
Beta2y	0.26
Ch YTD	-7.9
High	18,410
High52	21,300
High52 Date	2025-09-22
High52ch	-14.6%
Low	18,160
Low52	16,990
Low52 Date	2026-03-04
Low52ch	7.06%
Ma50ch	-1.36%
Price vs 200-day SMA	-6.3%
RSI	41.35
RSI Monthly	42.44
RSI Weekly	40.87
Sharpe ratio	0.23x
Sortino ratio	0.57
Total Return	6.4%
Tr YTD	-7.9
Tr15y	197.64%
Tr1m	1%
Tr1w	-2.41%
Tr3m	-5.26%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 23.2B
Operating Income Growth	0.64
Operating Income Growth Q	42.87
Operating Income Growth3 Y	-0.84
Operating Income Growth5 Y	12.79
Operating margin	8.46

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,174,296%
Net Borrowing	32,200,504,340
Shares Insiders	29.25%
Shares Institutions	1.18%
Shares Out	12,257,775
Shares Qo Q	-0.28%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -18.1B
Average Volume	19,267.3x
Bv Per Share	20,810.7
CAPEX	KRW -35.4B
Ch10y	-34.8
Ch15y	91.47
Ch1m	1
Ch1w	-2.41
Ch1y	2.31
Ch20y	67.86
Ch3m	-5.26
Ch3y	-20.39
Ch5y	-31.62
Ch6m	-8.08
Change	-1.14%
Change From Open	-1.2
Close	18,400
Days Gap	0.05
Depreciation Amortization	9,816,055,000
Dollar Volume	277,761,300
Earnings Date	2026-02-03
EBIT	KRW 23.2B
EBITDA	KRW 33B
EPS	KRW 1,728
F Score	3
FCF	KRW -18.1B
FCF Per Share	KRW -1,473
Financing CF	47,164,863,730
Fiscal Year End	December
Founded	1,968
Graham Number	28443.51219
Graham Upside	56.37
Income Tax	KRW 3.3B
Investing CF	-70,057,357,470
Is Primary Listing	1
Last Earnings Date	2026-02-03
Last Report Date	2013-09-30
Last Split Date	2010-12-29
Last Split Type	Forward
Lynch Fair Value	KRW 43,195
Lynch Upside	137.5
Ma150	19,325.6
Ma150ch	-5.88%
Ma20	18,671
Ma20ch	-2.58%
Net CF	-5,599,265,280
Open	18,410
P OCF Ratio	12.89
Payment Date	2026-04-20
Position In Range	12
Ppne	62,644,386,623
Price Date	2026-05-08
Price EBITDA	KRW 6.76
Ptbv Ratio	0.84
Relative Volume	0.79x
Revenue	274,031,808,440x
Tax By Revenue	1.21x
Tax Rate	13.18%
Tr20y	176.03%
Tr6m	-4.4%
Volume	15,270
Z Score	3.25

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KRX/005500 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+4.4%

$800 annual per share

Payout ratio

+45.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

0 consecutive years of growth

Total shareholder yield

+6.4%

Next ex-dividend date: 2025-12-29

Performance

KRX/005500 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/005500?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.2%

Share of float held by funds and institutions

Insider ownership

+29.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

KRX/005500 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.3

Neutral momentum band

Price vs 200-day MA

-6.3%

50/200-day relationship not available

Beta (5Y)

0.17

Less volatile than the market

Sharpe ratio

0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/005500

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/005500 stock rating?

krx/005500 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/005500 analysis?

The full report lives at /stocks/krx/005500/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/005500?

The latest report frames krx/005500 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/005500 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.